Illumina Inc (ILMN)

$416.52 7.37 (1.80%)

14:03 EDT ILMN Stock Quote Delayed 30 Minutes

Forget About the Genomic Revolution, the Proteomic Revolution Is Coming

By Luke Lango, InvestorPlace Senior Investment Analyst Sep 3, 2021

Thanks to one small protein sequencing startup, we're entering a new era of proteomics via NGPS technologies that will enable massively parallel protein sequencing.

Forget About the Genomic Revolution, the Proteomic Revolution Is Coming

7 Great Growth Stocks to Buy Now to Build Your Portfolio

Illumina Stock Will Be Unstoppable Once the Grail Acquisition Gets Approved

Volume:

Previous Close -

Market Cap 61.10B

PE Ratio 79.79

EPS 5.22

Volume (Avg. Vol.) 376,230

Day's Range 408.38 - 417.83

52-Week Range 288.01 - 555.77

Dividend & Yield N/A (N/A)

ILMN Stock Predictions, Articles, and Illumina Inc News

From InvestorPlace
From the Web

5 Healthcare Stocks to Buy for Their Game-Changing Potential

By Larry Ramer, InvestorPlace Contributor Jun 8, 2021

These healthcare stocks are at the forefront of huge trends, including precision medicine and advances in diagnosis technologies.

7 Beaten-Down Stocks to Buy Right Now for a June Rebound

By Tezcan Gecgil, InvestorPlace Contributor Jun 7, 2021

Are you looking for stocks that have been beaten up in recent weeks? Here are seven stocks to buy right now at the start of the summer.

7 Healthcare Stocks to Buy and Hold for the Long Term

By Faisal Humayun Mar 12, 2021

These steady, strong healthcare stocks are great picks for investors to buy and hold onto for at least the next five years.

7 Healthcare Stocks to Buy With the Sector Under Scrutiny

By Tom Taulli, InvestorPlace Writer & IPO Playbook Editor Dec 21, 2020

True, there are political risks in the industry. But there are also lots of growth opportunities for investors in healthcare stocks.

7 Unhealthy Biotech Stocks To Sell Before They Sicken Your Portfolio

By Louis Navellier and the InvestorPlace Research Staff Oct 23, 2020

It’s a good time to separate the weak from the strong.

Illumina News: ILMN Stock Slides Lower on $8 Billion Grail Deal

By Nick Clarkson, Web Editor Sep 21, 2020

Illumina's news of its $8 billion deal to acquire Grail, a healthcare company focused on cancer detection, has ILMN stock down on Monday.

Illumina News: ILMN Stock 4% Lower on Weak 2020 Outlook

By William White, InvestorPlace Writer Jan 13, 2020

Illumina (ILMN) news for Monday includes ILMN stock falling on a weak outlook for 2020, as well as some other news about a deal.

Investors Should Wait for Sky-High Valuations on Illumina Stock to Deflate

By Mark R. Hake, CFA Nov 4, 2019

You pay a high price for a company with near monopoly like Illumina. ILMN stock has 70% market share, but Its valuation is too high.

VIDEO: Biotech Stocks and the Future of Healthcare

By InvestorPlace Staff Sep 24, 2019

Tune in to 'Moneyline' to learn more about new opportunities in biotech stocks and how else to invest in the future of healthcare.

Nasdaq Today: Amazon Prime Day; Facebook Settles With FTC

By Bret Kenwell, InvestorPlace Contributor Jul 12, 2019

Facebook is reportedly settling with the FTC, Illumina warns on earnings and Amazon Prime Day is nearing in the Nasdaq Today.

4 Top Stock Trades for Monday:JNJ, SQ, ILMN, ACB

By Bret Kenwell, InvestorPlace Contributor Jul 12, 2019

Square, Johnson & Johnson, Illumina, Canopy Growth and Aurora Cannabis are our top stock trades for Monday.

Illumina News: Why ILMN Stock Is Plummeting

By William White, InvestorPlace Writer Jul 12, 2019

Illumina news for Friday concerning early results for the second quarter of 2019 that are below estimates is hitting ILMN stock hard.

Nasdaq Today: Apple Loses Ive and the Nasdaq’s Q3 Outlook

By Bret Kenwell, InvestorPlace Contributor Jun 28, 2019

The second quarter is the books, at least as far as the stock market is concerned. Here's a look at the Nasdaq today.

8 Genomic Testing Stocks That Can Ease the Sting of Theranos

By James Brumley, InvestorPlace Feature Writer Mar 27, 2019

InVitae, Crispr and Myriad are just some of the genomic testing stocks worth a look as DNA becomes a more important part of healthcare.

10 Smart Money Stocks to Buy Now

By Harriet Lefton, Writer, TipRanks Feb 19, 2019

Hedge funds have just released their trades for the fourth quarter, indicating some of the best stocks to buy now.

10 Stocks to Sell in February

By James Brumley, InvestorPlace Feature Writer Jan 29, 2019

Alphabet, Fiserv and Caterpillar are three of the 10 stocks you have to sell to sidestep trouble in the immediate future.

10 Stocks That Can Move Higher Whatever Happens

By Harriet Lefton, Writer, TipRanks Dec 12, 2018

Morgan Stanley says these stocks are set to outperform even if the market slows down in 2019. That makes these 10 excellent stocks to buy for careful investors.

3 DNA Stocks That Are on the Uptrend

By InvestorPlace Research Staff Nov 12, 2018

The future of genetic medicine is bright, but bumpy. But these bumps will provide many opportunities to buy DNA stocks along the way.

Nasdaq ETF Hits New Highs: 5 Stocks Up More Than 50%

By Zacks Investment Research Aug 28, 2018

Though most of the stocks in the Nasdaq ETF portfolio delivered strong returns so far this year, a few were the real stars, having gained more than 50%. Compare....